Public Joint-Stock Company Pharmacy Chain 36.6 (APTK.ME)

RUB 12.5

(-0.03%)

EBITDA Summary of Public Joint-Stock Company Pharmacy Chain 36.6

  • Public Joint-Stock Company Pharmacy Chain 36.6's latest annual EBITDA in 2022 was 10.44 Billion RUB , up 46.27% from previous year.
  • Public Joint-Stock Company Pharmacy Chain 36.6's latest quarterly EBITDA in 2023 Q2 was 1.65 Billion RUB , down 0.0% from previous quarter.
  • Public Joint-Stock Company Pharmacy Chain 36.6 reported an annual EBITDA of 7.6 Billion RUB in 2021, up 14.18% from previous year.
  • Public Joint-Stock Company Pharmacy Chain 36.6 reported an annual EBITDA of 9.72 Billion RUB in 2020, up 41.04% from previous year.
  • Public Joint-Stock Company Pharmacy Chain 36.6 reported a quarterly EBITDA of 1.65 Billion RUB for 2023 Q1, down 0.0% from previous quarter.
  • Public Joint-Stock Company Pharmacy Chain 36.6 reported a quarterly EBITDA of - RUB for 2022 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Public Joint-Stock Company Pharmacy Chain 36.6 (2022 - 2007)

Historical Annual EBITDA of Public Joint-Stock Company Pharmacy Chain 36.6 (2022 - 2007)

Year EBITDA EBITDA Growth
2022 10.44 Billion RUB 46.27%
2021 7.6 Billion RUB 14.18%
2020 9.72 Billion RUB 41.04%
2019 1.22 Billion RUB 213.1%
2018 -10.02 Billion RUB 160.55%
2017 -7.41 Billion RUB 44.36%
2016 -5.39 Billion RUB -10156.1%
2015 41 Million RUB -95.42%
2014 901 Million RUB 111.8%
2013 -7.62 Billion RUB -884.5%
2012 2.97 Billion RUB -64.5%
2011 1.99 Billion RUB 56.87%
2010 1.73 Billion RUB 22.29%
2009 1.8 Billion RUB 199.37%
2008 474.82 Million RUB 155.95%
2007 -848.71 Million RUB 0.0%

Peer EBITDA Comparison of Public Joint-Stock Company Pharmacy Chain 36.6

Name EBITDA EBITDA Difference